Because of disruptions to the drug supply and the need to purchase and use drugs in settings where it may be difficult to protect themselves and others from risk of infection, COVID-19 presents unique challenges for people who use drugs. These challenges have reignited conversations about creating safe and legal access to drugs. COVID-19 has impacted access to drugs and associated risks, and in so doing, has provided an opportunity to envision how things could look differently under a system of legal regulation.
This is the sixth in a series of seven discussions that DPA held on COVID-19 and drug policy. These discussions bring together advocates and allies in the justice reform movement to discuss how we can sustain progress, which obstacles still remain, and how we can use the current moment to be more aspirational with our policy agendas.
Moderators: Hannah Hetzer & Jules Netherland, Drug Policy Alliance